These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7587931)

  • 1. Acetylation and its role in the mutagenicity of the antihypertensive agent hydralazine.
    Lemke LE; McQueen CA
    Drug Metab Dispos; 1995 May; 23(5):559-65. PubMed ID: 7587931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity of hydralazine in mammalian cells and bacteria.
    McQueen CA; Way BM; Queener SM
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):135-8. PubMed ID: 8430421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity of 4-aminobiphenyl and 4-acetylaminobiphenyl in Salmonella typhimurium strains expressing different levels of N-acetyltransferase.
    Dang LN; McQueen CA
    Toxicol Appl Pharmacol; 1999 Sep; 159(2):77-82. PubMed ID: 10495770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo testing of hydralazine genotoxicity.
    Martelli A; Allavena A; Campart GB; Canonero R; Ghia M; Mattioli F; Mereto E; Robbiano L; Brambilla G
    J Pharmacol Exp Ther; 1995 Apr; 273(1):113-20. PubMed ID: 7714756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic effects of binazine and hydralazine in vitro and in vivo.
    Chłopkiewicz B; Ejchart A; Marczewska J
    Acta Pol Pharm; 1995; 52(1):31-3. PubMed ID: 8960236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of N-Acetyltransferase 2 Genotype on the Pharmacokinetics of Hydralazine During Pregnancy.
    Han LW; Ryu RJ; Cusumano M; Easterling TR; Phillips BR; Risler LJ; Shen DD; Hebert MF
    J Clin Pharmacol; 2019 Dec; 59(12):1678-1689. PubMed ID: 31257615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of hydralazine induced mutagenicity and genotoxicity.
    Chopkiewicz B; Ejchart A; Marczewska J
    Acta Pol Pharm; 1995; 52(3):219-22. PubMed ID: 8960252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between mechanistic biotransformation and biochemical toxicology of some antihypertensive drugs.
    Akintonwa DA
    Drug Des Deliv; 1986 Nov; 1(2):143-50. PubMed ID: 3509327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylation status using hydralazine in African hypertensives at Kenyatta National Hospital.
    Rashid JR; Kofi-Tsepko ; Juma FD
    East Afr Med J; 1992 Jul; 69(7):406-8. PubMed ID: 1396201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic toxicity of several antihypertensive drugs possessing a hydrazine group.
    Kitamura J; Mori H; Sugie S; Kawai K
    Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):415-22. PubMed ID: 4059657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant spectra analysis at hisG46 in Salmonella typhimurium strain YG1029 induced by mammalian S9- and plant-activated aromatic amines.
    Ju YH; Plewa MJ
    Teratog Carcinog Mutagen; 2003; Suppl 1():47-60. PubMed ID: 12616596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced mutation spectra at the upp locus in Salmonella typhimurium: response of the target gene in the FU assay to mechanistically different mutagens.
    Vlasakova K; Skopek TR; Glaab WE
    Mutat Res; 2005 Oct; 578(1-2):225-37. PubMed ID: 16143350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity of bisphenol A (4,4'-isopropylidenediphenol) in vitro: effects of nitrosylation.
    Schrader TJ; Langlois I; Soper K; Cherry W
    Teratog Carcinog Mutagen; 2002; 22(6):425-41. PubMed ID: 12395404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse.
    Sugamori KS; Brenneman D; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
    Drug Metab Dispos; 2007 Jul; 35(7):1064-70. PubMed ID: 17403913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human acetyl CoA:arylamine N-acetyltransferase variants generated by random mutagenesis.
    Summerscales JE; Josephy PD
    Mol Pharmacol; 2004 Jan; 65(1):220-6. PubMed ID: 14722254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs.
    Palamanda JR; Hickman D; Ward A; Sim E; Romkes-Sparks M; Unadkat JD
    Drug Metab Dispos; 1995 Apr; 23(4):473-7. PubMed ID: 7600914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.